I believe those are the most likely outcomes Wild1.
There is no obvious reason for any reduction in US dose sales and I think if any change it will be an increase in % growth rate of US dose sales due to SIRFLOX finally having a full FY's impact on sales.
July low of $25.10 needs to hold, page-15
-
- There are more pages in this discussion • 42 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SRX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
15.5¢ |
Change
0.005(3.33%) |
Mkt cap ! $65.79M | |||
| Open | High | Low | Value | Volume |
| 15.5¢ | 16.0¢ | 15.5¢ | $265.9K | 1.683M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 1676329 | 15.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 16.0¢ | 4171508 | 29 |
View Market Depth
| Last trade - 16.10pm 02/07/2024 (20 minute delay) ? |
| SRX (ASX) Chart |